It would seem unlikely they will be able to get FDA approval in the US if they are unable to get TGA in Australia.
They would need data from a trial that the FDA deem satisfactory.
OSL Price at posting:
6.1¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)